Recently Viewed

News Announcement

Titan Bio-Tech: Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

17-Jun-2020 Follow Value Research Online on Google download pdfDownload PDF Titan Bio-Tech

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Suresh Chad Sangla

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds